Alpha Teknova, Inc. Stock News

Alpha Teknova, Inc. (NASDAQ:TKNO ) Q1 2022 Earnings Conference Call May 11, 2022 4:30 PM ET Company Participants Sara Michelmore - Head of Investor Relations, MacDougall Advisors Stephen Gunstream - P

HOLLISTER, Calif., May 04, 2022 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading provider of critical reagents for the discovery, development, and commercialization of

Alpha Teknova press release (NASDAQ:TKNO): Q4 GAAP EPS of -$0.13 beats by $0.07.Revenue of $10.11M (-0.5% Y/Y) beats by $1.64M.

Alpha Teknova's (TKNO) CEO Stephen Gunstream on Q4 2021 Results - Earnings Call Transcript

HOLLISTER, Calif., March 02, 2022 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading provider of critical reagents for the discovery, development, and commercialization of drug therapies, novel vaccines, and molecular diagnostics, today announced that the Company will report its financial results for the fourth quarter and full year 2021 on Tuesday, March 15, 2022, following the close of market.

HOLLISTER, Calif., March 02, 2022 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading provider of critical reagents for the discovery, development, and commercialization

Alpha Teknova (TKNO) has reported its preliminary estimates for fourth quarter with revenue expected to range between $10-$10.1M (-1% Y/Y) that is above the consensus of…

HOLLISTER, Calif., Feb. 14, 2022 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading provider of critical reagents for the development and production of biopharmaceutical

HOLLISTER, Calif., Dec. 15, 2021 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (Teknova) (Nasdaq: TKNO), a leading provider of critical reagents for the development and production of biopharmaceutical products, including drug therapies, novel vaccines, and molecular diagnostics, today announced that it will join the Nasdaq Biotechnology Index® (Nasdaq: NBI) effective prior to market open on Monday, December 20, 2021.

Alpha Teknova, Inc. (NASDAQ:TKNO) shares gapped up prior to trading on Monday . The stock had previously closed at $17.49, but opened at $18.60. Alpha Teknova shares last traded at $18.10, with a volume of 166 shares changing hands. A number of research analysts have weighed in on the stock. Cowen lifted their price objective […]

Alpha Teknova, Inc. (NASDAQ:TKNO) gapped up before the market opened on Friday . The stock had previously closed at $20.52, but opened at $21.24. Alpha Teknova shares last traded at $19.64, with a volume of 89 shares trading hands. Several brokerages recently commented on TKNO. Zacks Investment Research raised Alpha Teknova from a sell rating []

Alpha Teknova, Inc. (NASDAQ:TKNO) was the target of a large decline in short interest in November. As of November 15th, there was short interest totalling 202,600 shares, a decline of 25.7% from the October 31st total of 272,800 shares. Based on an average daily volume of 110,900 shares, the short-interest ratio is presently 1.8 days. []